StonvexLoading…
StonvexStonvexStonvexCore line items from CNVS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $78.18M | $49.13M | $68.03M | $56.05M |
Operating Income | $7.92M | $-15.70M | $-8.92M | $-925.00K |
Net Income | $3.76M | $-21.27M | $-9.69M | $2.27M |
EPS (Diluted) | $0.16 | $-1.78 | $-1.13 | $0.20 |
Total Assets | $72.52M | $64.38M | $87.99M | $104.64M |
Total Liabilities | $34.72M | $32.23M | $48.91M | $63.69M |
Cash & Equivalents | $13.94M | $5.17M | $7.15M | $13.06M |
Free Cash Flow OCF − CapEx | Not available | $-11.66M | $-10.07M | $4.56M |
Shares Outstanding | 17.82M | 12.25M | 8.89M | 8.69M |